TrialBMC health services research2023

Infliximab versus ciclosporin in steroid resistant acute severe ulcerative colitis: a model-based cost-utility analysis of data from CONSTRUCT pragmatic trial.

Mohammed Fasihul Alam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.